Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AMRI, Navigen Enter Research Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

AMRI, Navigen Enter Research Pact

AMRI has entered a multi-year research collaboration with Navigen Pharmaceuticals focused on the development of new drug therapies.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI has entered a multi-year research collaboration with Navigen Pharmaceuticals focused on the development of new drug therapies. AMRI will provide drug discovery services including assay development, screening, in vitro ADMET, computer-aided drug discovery (CADD) and medicinal chemistry.

“AMRI has a proven track record of success working with biotech companies such as Navigen,” said Michael P. Trova, Ph.D., senior vice president, chemistry. “Our ability to execute integrated biology and chemistry services under the helm of an experienced project manager ensures best practices are applied to the delivery of high quality preclinical candidates with a strong intellectual property position to our customers. We look forward to the opportunity to work with Navigen to help advance their early drug discovery efforts.

Click here to learn more about AMRI

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics